Cytokine storm and an anti-CD28 monoclonal antibody

被引：0
|
作者：
Corry, David B. [1 ]
Lewis, Dorothy E. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 24期
关键词：
TOXIC-SHOCK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2592 / 2592
页数：1
相关论文
共 50 条
  • [1] Anti-CD28 Antibody-Initiated Cytokine Storm in Canines
    Rosinski, Steven L.
    Storb, Rainer
    Strong, Roland K.
    Sale, George E.
    Stone, Diane M.
    Gewe, Mesfin M.
    Friend, Della J.
    Abrams, V. Kraig
    Randolph-Habecker, Julie
    Graves, Scott S.
    TRANSPLANTATION DIRECT, 2015, 1 (02): : E7
  • [2] Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
    Suntharalingam, Ganesh
    Perry, Meghan R.
    Ward, Stephen
    Brett, Stephen J.
    Castello-Cortes, Andrew
    Brunner, Michael D.
    Panoskaltsis, Nicki
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10): : 1018 - 1028
  • [3] Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm
    Nicki Panoskaltsis
    Neil E. McCarthy
    Andrew J. Stagg
    Catherine J. Mummery
    Mariwan Husni
    Naila Arebi
    David Greenstein
    Claire L. Price
    Hafid O. Al-Hassi
    Michalis Koutinas
    Athanasios Mantalaris
    Stella C. Knight
    Cancer Immunology, Immunotherapy, 2021, 70 : 1127 - 1142
  • [4] Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm
    Panoskaltsis, Nicki
    McCarthy, Neil E.
    Stagg, Andrew J.
    Mummery, Catherine J.
    Husni, Mariwan
    Arebi, Naila
    Greenstein, David
    Price, Claire L.
    Al-Hassi, Hafid O.
    Koutinas, Michalis
    Mantalaris, Athanasios
    Knight, Stella C.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (04) : 1127 - 1142
  • [5] A novel mouse model for superagonistic anti-CD28 monoclonal antibody-induced cytokine release syndrome in humans
    Haack, S.
    Langenhorst, D.
    Sparwasser, T.
    Beyersdorf, N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 272 - 272
  • [6] Cytotoxic difference of T cells expanded with anti-CD3 monoclonal antibody in the presence and absence of anti-CD28 monoclonal antibody
    Yamada-Ohnishi, Y
    Azuma, H
    Urushibara, N
    Yamaguchi, M
    Fujihara, M
    Kobata, T
    Ikeda, H
    STEM CELLS AND DEVELOPMENT, 2004, 13 (03) : 315 - 322
  • [7] GENERATION AND FUNCTIONAL-CHARACTERIZATION OF A HUMANIZED ANTI-CD28 MONOCLONAL-ANTIBODY
    KUHN, K
    LEWIS, AP
    WALDMANN, H
    CROWE, JS
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 191 - 191
  • [8] Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats
    Laskowski, IA
    Pratschke, J
    Wilhelm, MJ
    Dong, VM
    Beato, F
    Taal, M
    Gasser, M
    Hancock, WW
    Sayegh, MH
    Tilney, NL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (02): : 519 - 527
  • [9] The superagonistic monoclonal anti-CD28 antibody modulates cytokine expression in mononuclear blood cells of multiple sclerosis patients and healthy controls
    Hofstetter, H
    Franz, C
    Gronen, F
    Buttmann, M
    Ruprecht, K
    Hanke, T
    Hünig, T
    Toyka, K
    Rieckmann, P
    MULTIPLE SCLEROSIS, 2005, 11 : S167 - S167
  • [10] Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities
    Shiao, Stephen L.
    McNiff, Jennifer M.
    Masunaga, Taro
    Tamura, Kouichi
    Kubo, Kaori
    Pober, Jordan S.
    TRANSPLANTATION, 2007, 83 (03) : 304 - 313
12345